These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2369555)

  • 1. A study of etretinate alopecia.
    Berth-Jones J; Shuttleworth D; Hutchinson PE
    Br J Dermatol; 1990 Jun; 122(6):751-5. PubMed ID: 2369555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel cycle changes in scalp hair are caused by etretinate therapy.
    Berth-Jones J; Hutchinson PE
    Br J Dermatol; 1995 Mar; 132(3):367-75. PubMed ID: 7718452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cutaneous lupus erythematosus with etretinate.
    Ruzicka T; Meurer M; Braun-Falco O
    Acta Derm Venereol; 1985; 65(4):324-9. PubMed ID: 2413687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapeutic efficacy of tigazon in treating dermatoses].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Kriazheva SS; Butov IuS
    Vestn Dermatol Venerol; 1990; (5):4-6. PubMed ID: 2402940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced hair loss and hair growth. Incidence, management and avoidance.
    Tosi A; Misciali C; Piraccini BM; Peluso AM; Bardazzi F
    Drug Saf; 1994 Apr; 10(4):310-7. PubMed ID: 8018303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telogen effluvium due to recombinant interferon alpha-2b.
    Tosti A; Misciali C; Bardazzi F; Fanti PA; Varotti C
    Dermatology; 1992; 184(2):124-5. PubMed ID: 1498373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hair root pattern after calcipotriol treatment for scalp psoriasis.
    Kuijpers AL; van Baar HM; van Gasselt MW; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):388-90. PubMed ID: 8615060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Curling and kinking of hair caused by etretinate].
    Schauder S; Tsambaos D; Nikiforidis G
    Hautarzt; 1992 Aug; 43(8):509-13. PubMed ID: 1506218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finasteride increases anagen hair in men with androgenetic alopecia.
    Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
    Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs and hair loss.
    Patel M; Harrison S; Sinclair R
    Dermatol Clin; 2013 Jan; 31(1):67-73. PubMed ID: 23159177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
    Castel T; Castro J; Lecha M; Mascaró JM
    Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular density and ratios in scarring and nonscarring alopecia.
    Horenstein MG; Bacheler CJ
    Am J Dermatopathol; 2013 Dec; 35(8):818-26. PubMed ID: 23435361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anagen effluvium secondary to
    Bains A; Verma GK; Vedant D; Negi A
    Indian J Dermatol Venereol Leprol; 2016; 82(6):677-680. PubMed ID: 27451928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study.
    Kanti V; Nuwayhid R; Lindner J; Hillmann K; Stroux A; Bangemann N; Kleine-Tebbe A; Blume-Peytavi U; Garcia Bartels N
    Br J Dermatol; 2014 Mar; 170(3):643-50. PubMed ID: 24641211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)].
    Solano E; Hidalgo H
    Med Cutan Ibero Lat Am; 1983; 11(5):369-71. PubMed ID: 6230492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' acceptance of etretinate therapy. A retrospective survey of long-term etretinate therapy in chronic keratotic and pustular skin diseases.
    Christiansen JV; Holm P; Reymann F; Thestrup-Pedersen K
    Dermatologica; 1984; 168(3):122-6. PubMed ID: 6714503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etretinate may work where acitretin fails.
    Bleiker TO; Bourke JF; Graham-Brown RA; Hutchinson PE
    Br J Dermatol; 1997 Mar; 136(3):368-70. PubMed ID: 9115918
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.